found that circHIPK3 could promote cardiac endothelial cell cycle progression and proliferation by reducing miR‐29a activity and increasing vascular endothelial growth factor A (VEGFA) expression, thus alleviating damage after MI. This evidence concerns the gene VEGFA and myocardial infarction.